Cancer Research and Treatment

Cancer Research and Treatment Search

> Browse Articles > Search

Genitourinary Cancer

Neoadjuvant Chemotherapy–Guided Bladder-Sparing Treatment for Muscle-Invasive Bladder Cancer: Results of a Pilot Phase II Study

Hongzhe Shi, Wen Zhang, Xingang Bi, Dong Wang, Zejun Xiao, Youyan Guan, Kaopeng Guan, Jun Tian, Hongsong Bai, Linjun Hu, Chuanzhen Cao, Weixing Jiang, Zhilong Hu, Jin Zhang, Yan Chen, Shan Zheng, Xiaoli Feng, Changling Li, Yexiong Li, Jianhui Ma, Yueping Liu, Aiping Zhou, Jianzhong Shou

Cancer Res Treat. 2021;53(4):1156-1165. Published online February 10, 2021 DOI: https://doi.org/10.4143/crt.2020.1356

Web of Science 9 Crossref 10

Prevalence and Clinicopathological Significance of MET Overexpression and Gene Amplification in Patients with Gallbladder Carcinoma

Yeseul Kim, Seong Sik Bang, Seungyun Jee, Sungeon Park, Su-Jin Shin, Kiseok Jang

Cancer Res Treat. 2020;52(2):481-491. Published online October 24, 2019 DOI: https://doi.org/10.4143/crt.2019.370

Web of Science 10 Crossref 8

Previous Bladder Cancer History in Patients with High-Risk, Non–muscle-invasive Bladder Cancer Correlates with Recurrence and Progression: Implications of Natural History

Lampros P. Mitrakas, Ioannis V. Zachos, Vassileios P. Tzortzis, Stavros A. Gravas, Erasmia C. Rouka, Konstantinos I. Dimitropoulos, Gerasimos P. Vandoros, Anastasios D. Karatzas, Michael D. Melekos, Athanasios G. Papavassiliou

Cancer Res Treat. 2015;47(3):495-500. Published online September 11, 2014 DOI: https://doi.org/10.4143/crt.2014.050

Web of Science 2 Crossref 3

Clinical Prognostic Factors for Radical Cystectomy in Bladder Cancer

Seung Hyun Jeon, Sung-Hyun Jeon, Sung-Goo Chang

Cancer Res Treat. 2005;37(1):48-53. Published online February 28, 2005 DOI: https://doi.org/10.4143/crt.2005.37.1.48

Crossref 3

Growth Suppression and Induction of Chemosensitivity in Human Gallbladder Epithelial Carcinoma Cells (GBCE) by Adenovirus-Mediated Transfer of the Wild-type p53 Gene

Sung Bae Kim, Myung Hwan Kim, Sung Koo Lee, Tae Won Kim, Cheolwon Suh, Jeong Sik Shin, Jung Sun Park, Eun Soon Kim, Gyungyub Gong, Jung Shin Lee, Woo Kun Kim, Sang Hee Kim

Cancer Res Treat. 2003;35(6):521-527. Published online December 31, 2003 DOI: https://doi.org/10.4143/crt.2003.35.6.521

Association of Genetic Polymorphism of Glutathions S-transferase M1 and T1 and Bladder Cancer

Seung Joon Lee, Dae Hee Kang, Soo Hun Cho, Soo Woong Kim, Moon Soo Park, Han Yong Choi, Whang Choi

J Korean Cancer Assoc. 1999;31(3):548-555.

The Significance of Urinary Nuclear Matrix Protein ( NMP22 ) Measurement in Patients with transitional Cell Carcinoma of the Bladder

Seok Heun Jang, Hak Ryong Choi, Bong Suk Shim, Sung Won Kwon

J Korean Cancer Assoc. 1998;30(6):1227-1230.

The Clinical Usefulness of Membranous E-cadherin in Transitional Cell Carcinoma of the Bladder

Bong Ryoul Oh, Gil Joo Nah, Seong Jin Kim, Jae Hong Sim, Dong Deuk Kwon, Kwang Sung Park, Soo Bang Ryu, Yang Il Park

J Korean Cancer Assoc. 1998;30(6):1219-1226.

Urinary Nuclear Matrix Protein ( NMP 22 ) in the Detection of Transitional Cell Carcinoma of the Bladder

Soo Bang Ryu, Bong Ryoul Oh, Soon Pal Suh, Dong Deuk Kwon, Je Woong Ryu, Yang Il Park

J Korean Cancer Assoc. 1998;30(2):378-383.

Prediction of Lymph Node Metastasis Based on p53 and nm23-H1 Expression in Muscle Invasive Grade 3 Transitional Cell Carcinoma of Bladder

Dong Soo Park, Jin Moo Lee

J Korean Cancer Assoc. 1996;28(2):326-336.

Expression of CD44 Splice Variant mRNA in Bladder Cancers and its Diagnostic Application

Min Ho Suh, Won Ki Baek, Jong Wook Park, Chun Il Kim, Min Ho Suh, Byung Kil Choe

J Korean Cancer Assoc. 1995;27(3):451-459.

Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410 FAX: +82-2-792-1410 E-mail: journal@cancer.or.kr

About | Browse Articles | Current Issue | For Authors and Reviewers